MIRA
INFORM REPORT
|
Report Date : |
17.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
ALSON PHARMACEUTICALS |
|
|
|
|
Registered Office : |
Plot # 169, Industrial Estate, Hayatabad, Peshawar |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1999 |
|
|
|
|
Com. Reg. No.: |
1693466 |
|
|
|
|
Legal Form : |
Partnership Business |
|
|
|
|
Line of Business : |
Manufacture
& Marketing of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Business Name
ALSON PHARMACEUTICALS
Full Address
Registered Address & Factory
Plot # 169, Industrial Estate, Hayatabad, Peshawar, Pakistan
Tel 92
(21) 5825872
Fax 92
(21) 5828164
Short Description Of
Business
Nature of Business Manufacture & Marketing of Pharmaceutical
Products
Year
Established 1999
National
Tax # 1693466
Branches
None
Legal Status
Subject Company was established as a Partnership business in 1999
Details of Management
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Abdul Habib Mr.Muhammad Tufail Mr. Hameed Ahmed Mr. Momeen Gul Mr. Saif-Ul-Islam |
Pakistani Pakistani Pakistani Pakistani Pakistani |
169, Industrial Estate, Hayatabad, Peshawar 169, Industrial Estate, Hayatabad, Peshawar 169, Industrial Estate, Hayatabad, Peshawar 169, Industrial Estate, Hayatabad, Peshawar 169, Industrial Estate, Hayatabad, Peshawar |
Business Business Business Business Business |
Managing Partner Partner Partner Partner Partner |
Associates
SUBSIDIARY
None
ASSOCIATED COMPANIES
- Do -
Products
Subject Company is engaged in manufacture & marketing of Pharmaceutical Products.
It purchases raw material against D/A basis.
Its’ major customers are Distributors, Traders, Pharmacies & Hospitals located in Peshawar.
Subject operates from caption leased factory premises of area measuring 2,000 Sq.Yard. which is situated in industrial area.
Subject employs about 44 persons in its set up
Products
ALBONE, ALCIDE,
ALCRABANE, ALDAL, ALDINE, ALDOXY, ALEXIN ALFEN, ALKET, ALLUM, ALMEB, ALMEF,
ALMEF FORT, ALMENDAL, ALMICOBAL, ALMOL, ALMOX, ALOMEP, ALOXI, ALOXIN, ALPHEM,
ALPROF, ALRAL, ALREN, ALSOLIDE, ALTAD, ALTAL, ALVIDOX, ALWORM, ALZEX, AMFLOX,
AMLOPAL, APENTRAL, BIOLIDE, CEFBEN, CEFDAL, CELOCEF, CIMETAI, COTRIMAXAL,
DEPTIN, FENAL, FIXIL, FLUORAL, FUCEF, LANSOPAL, MACROPORE, NORAL, PHENPAL,
TIZENEDAL
Annual Sales Volume
|
Year |
In Pak Rupees
|
|
2006 |
15,000,000/-
(Estimated) |
Capacity &
Production
The capacity and production of the company’s plant is indeterminable as it is multi- product and involves various processes of manufacture.
Authorized
Distributors
Mainly in Peshawar
Bankers
Habib Bank Limited,
Pakistan
MCB Bank Limited,
Pakistan
Bank of Khyber,
Pakistan
Bank Alfalah
Limited, Pakistan
Foreign Exchange
Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 62.50 |
|
UK Pound |
1 |
Rs. 122.30 |
|
Euro |
1 |
Rs. 92.40 |
Comments
Subject Company was established in
1999 and is engaged in manufacture & marketing of Pharmaceutical Products. Trade relations are reported as fair. The Company
can be considered for normal business dealings at usual trade terms and
conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)